Reference priceKRW ₩198,956.25Original source price: INR 12,281.25. Converted estimates are available by currency selection.
| Brand | Hetero Healthcare Ltd |
|---|---|
| Manufacturer | Hetero Healthcare Ltd. |
| Prescription required | Yes |
Acalnib 100mg Capsule
Acalabrutinib (100mg)
Description
Acalnib 100mg Capsule is an anticancer medicine containing the active constituent Acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected.Benefits
The Acalnib 100mg Capsule is used in the treatment of 1.Chronic lymphocytic leukemia 2.Small lymphocytic lymphoma 3.Mantle cell lymphomaHow to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Acalnib Anemia (low number of red blood cells) Decreased white blood cell count (neutrophils) Upper respiratory tract infection Low blood platelets Headache Diarrhea Musculoskeletal (bone, muscle or joint) pain이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.